1.The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer
Journal of Gynecologic Oncology 2020;31(1):40-
No abstract available.
Anticoagulants
2.Which of the Direct Oral Anticoagulants Is the Safest?: Based on Gastrointestinal Bleeding.
The Korean Journal of Gastroenterology 2017;69(5):328-331
No abstract available.
Anticoagulants*
;
Hemorrhage*
3.New Anticoagulants and Status of Their Clinical Trials in the Management of Deep Vein Thrombosis.
Journal of the Korean Society for Vascular Surgery 2009;25(1):86-94
No abstract available.
Anticoagulants
;
Venous Thrombosis
4.Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues.
Konark MALHOTRA ; Monica KHUNGER ; David S LIEBESKIND
Journal of Stroke 2017;19(1):104-106
No abstract available.
Anticoagulants*
;
Humans
;
Stroke*
5.Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism.
Blood Research 2014;49(2):77-79
No abstract available.
Anticoagulants*
;
Venous Thromboembolism*
6.Studies on In Vitro Blood Anticoagulant Effect of the Mixture of Ligusticum wallichii and Angelica acutiloba
Journal of Medicinal Materials - Hanoi 2003;8(2):49-52
Ethanol extract of the mixture of Ligusticum wallichii and Angelica acutiloba exerts significant anticoagulant effect on human blood in in vitro experiments. At concentration of 1:25 in the serum, the extract prolongs the prothrombin, thromboplastin and thrombin times, thus inhibits all the three steps of the coagulation process, i.e, the exogenous, the endogenous precoagulation steps and the formation of fibrins. Finally, at concentration of 1:50 in the serum, the mixture significantly reduces theplatelet aggregation blocking the clotting process.
Anticoagulants
;
Blood
;
Biochemistry
7.Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
Korean Circulation Journal 2018;48(5):433-434
No abstract available.
Anticoagulants
;
Atrial Fibrillation
;
Humans
8.Is stopping of anticoagulant therapy really required in a minor dental surgery?: How about in an endodontic microsurgery?.
Restorative Dentistry & Endodontics 2013;38(3):113-118
Nowadays, oral anticoagulants are commonly prescribed to numerous patients for preventing cardiovascular accident such as thromboembolism. An important side effect of anticoagulant is anti-hemostasis. In a major surgery, the oral anticoagulant therapy (OAT) regimen must be changed before the surgery for proper post-operative bleeding control. However, in a minor dental surgery and endodontic surgery, the necessity for changing or discontinuing the OAT is open to debate. In this study, risks of the consequences were weighed and analyzed. In patients who stop the OAT, the occurrence of thromboembolic complication is rare but the result is fatal. In patients who continuing the OAT, post-operative bleeding can be controlled well with the local hemostatic measures. In the endodontic surgery, there are almost no studies about this issue. The intra-operative bleeding control is particularly important in the endodontic surgery because of its delicate and sensitive procedures such as inspection of resected root surface using dental microscope and retrograde filling. Further studies are necessary about this issue in the viewpoint of endodontic surgery.
Anticoagulants
;
Avena
;
Hemorrhage
;
Humans
;
Thromboembolism
9.Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?
Journal of Stroke 2019;21(3):241-241
No abstract available.
Anticoagulants
;
Hematologic Agents
;
Atrial Fibrillation
Result Analysis
Print
Save
E-mail